JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nakamura, T. Articles by Asada, A. Search for Related Content PubMed PubMed Citation Articles by Nakamura, T. Articles by Asada, A. Related Collections Complications Patient Safety Preclinical Pharmacology Regional Anesthesia Pharmacology

---

ANESTHETIC PHARMACOLOGY

Propranolol Increases the Threshold for Lidocaine-Induced Convulsions in Awake Rats: A Direct Effect on the Brain

From the Department of Anesthesiology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Address correspondence and reprint requests to Yutaka Oda, MD, PhD, Department of Anesthesiology, Osaka City University Graduate School of Medicine, 1-5-7 Asahimachi, Abeno-ku, Osaka 545-8586, Japan. Address e-mail to odayou{at}msic.med.osaka-cu.ac.jp.

BACKGROUND: Propranolol is a β-adrenoceptor antagonist used clinically. Local anesthetics are used for controlling pain, whereas propranolol is concomitantly given to treat hypertension and tachycardia. However, there are few studies examining the effects of propranolol on the toxicity of local anesthetics. We investigated the effect of propranolol on lidocaine-induced convulsions in awake, spontaneously breathing rats.

METHODS: Male Sprague-Dawley rats were randomly divided into six groups (n = 8, each group). Rats were pretreated with intracerebroventricular saline (cerebroventricle- control: CV-C group), 10 or 30 µg/kg of (S)-(–)-propranolol (propranolol) (cerebroventricle-small dose: CV-S and cerebroventricle-large dose: CV-L groups, respectively) or IV saline (IV-control: IV-C group), 1 or 3 mg/kg of propranolol (IV-small dose: IV-S and IV-large dose: IV-L groups, respectively). Three minutes later, lidocaine was administered IV at 4 mg · kg^–1 · min^–1 until tonic-clonic convulsions occurred.

RESULTS: The convulsive dose of lidocaine in the CV-L group was significantly larger than that in the CV-C group (30.6 ± 5.1 vs 23.5 ± 2.2 mg/kg, respectively, P = 0.008). Plasma concentrations of total and protein-unbound lidocaine, concentrations of lidocaine in the brain at the onset of convulsions were also significantly higher in the CV-L group than those in the CV-C group (36.1 ± 4.8 vs 26.0 ± 3.8 µg/mL, 22.5 ± 3.5 vs 13.7 ± 2.6 µg/mL, 82.7 ± 7.1 vs 57.3 ± 5.7 µg/g, P < 0.001 for all). The convulsive dose, plasma concentrations of total and protein-unbound lidocaine, and brain lidocaine in the IV-L group were also significantly larger than those in IV-C group and comparable with those in the CV-L group. The plasma concentration of propranolol before starting an infusion of lidocaine in the IV-L group was approximately 60-fold higher than that in the CV-L group (554.7 ± 104.6 and 9.3 ± 6.7 ng/mL, respectively).

CONCLUSIONS: Propranolol increased the threshold for lidocaine-induced convulsions by directly acting on the brain.

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999